fluorodeoxyglucose f18 has been researched along with Genital Neoplasms, Male in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, M; Lin, P; Naik, N | 1 |
| Fujikawa, N; Hayashi, N; Ikeda, I; Mizuno, N; Murakami, T; Suzuki, K | 1 |
| Herrmann, K; Kohan, AA; Mihaloew, H; Paspulati, RM; Sherertz, T | 1 |
| Hsu, YL; Lin, IC; Tung, CL | 1 |
| Abdel Raheem, AM; Freeman, A; Garaffa, G; Minhas, S; Muneer, A; Ralph, DJ; Rees, RW | 1 |
| Conti, PS; Jadvar, H | 1 |
| Cho, SB; Chung, KY; Lee, MG; Yun, M | 1 |
| Aoyagi, S; Sato-Matsumura, KC; Shimizu, H | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Genital Neoplasms, Male
| Article | Year |
|---|---|
Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Genitalia, Female; Genitalia, Male; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pelvic Neoplasms; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
The reproductive tract.
Topics: Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2004 |
6 other study(ies) available for fluorodeoxyglucose f18 and Genital Neoplasms, Male
| Article | Year |
|---|---|
Genitourinary involvement of lymphomas on FDG-PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 2018 |
[A case of primary seminal vesicle cancer detected by FDG-PET/CT].
Topics: Aged; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seminal Vesicles; Tomography, X-Ray Computed | 2012 |
18F-FDG PET/CT of Seminal Vesicle Metastasis From Ascending Colon Adenocarcinoma.
Topics: Adenocarcinoma; Colon, Ascending; Colonic Neoplasms; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminal Vesicles | 2017 |
Paraganglioma of the spermatic cord: case report and review of the literature.
Topics: Adrenal Glands; Aged; CD56 Antigen; Chromogranin A; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Male; Paraganglioma; Positron-Emission Tomography; S100 Proteins; Spermatic Cord; Synaptophysin | 2008 |
Variable patterns of positron emission tomography in the assessment of patients with extramammary Paget's disease.
Topics: Aged; Bone Neoplasms; Fatal Outcome; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals; Scrotum; Sepsis | 2005 |
Staging and assessment of lymph node involvement by 18F-fluorodeoxyglucose-positron emission tomography in invasive extramammary Paget's disease.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Genital Neoplasms, Male; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paget Disease, Extramammary; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |